• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定与阿尔茨海默病早期tau蛋白负荷相关的认知测试分数。

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease.

作者信息

Terao Caitlin M, Alexander Madeline Wood, Chalmers R Philip, Boshmaf Silina Z, Paterson Jane, Black Sandra E, Papp Kathryn V, Sperling Reisa A, Rabin Jennifer S

机构信息

Hurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.

Department of Psychology, York University Toronto Ontario Canada.

出版信息

Alzheimers Dement (Amst). 2025 Jan 14;17(1):e70052. doi: 10.1002/dad2.70052. eCollection 2025 Jan-Mar.

DOI:10.1002/dad2.70052
PMID:39811702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11730071/
Abstract

INTRODUCTION

This study aimed to identify cognitive tests that optimally relate to tau positron emission tomography (PET) signal in the inferior temporal cortex (ITC), a neocortical region associated with early tau accumulation in Alzheimer's disease (AD).

METHODS

We analyzed cross-sectional data from the harvard aging brain study (HABS) (= 128) and the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) study (= 393). We used elastic net regression to identify the most robust cognitive correlates of tau PET signal in the ITC. Secondary analyses examined whether the cognitive correlates remained significantly associated with tau after adjusting for structural brain measures.

RESULTS

Episodic memory measures, including both total and "process" scores, were the most robust correlates of ITC tau across both cohorts. These cognitive test scores remained significant after accounting for structural brain measures.

DISCUSSION

These findings highlight the potential of specific episodic memory test scores to detect and monitor neuropathological changes associated with early AD.

HIGHLIGHTS

Machine learning identified cognitive correlates of early Alzheimer's disease tau burden.Both traditional and process scores predicted early tau burden.Episodic memory scores were among the strongest correlates.Cognitive scores remained significant after accounting for structural brain measures.

摘要

引言

本研究旨在确定与颞下回(ITC)中tau正电子发射断层扫描(PET)信号最相关的认知测试,ITC是与阿尔茨海默病(AD)早期tau积累相关的新皮质区域。

方法

我们分析了来自哈佛衰老大脑研究(HABS,n = 128)和无症状阿尔茨海默病抗淀粉样蛋白治疗(A4)研究(n = 393)的横断面数据。我们使用弹性网络回归来确定ITC中tau PET信号最可靠的认知相关性。二次分析检验了在调整脑结构测量指标后,认知相关性是否仍与tau显著相关。

结果

情景记忆测量指标,包括总分和“过程”分数,是两个队列中ITC tau最可靠的相关性指标。在考虑脑结构测量指标后,这些认知测试分数仍然具有显著性。

讨论

这些发现凸显了特定情景记忆测试分数在检测和监测与早期AD相关的神经病理变化方面的潜力。

要点

机器学习确定了早期阿尔茨海默病tau负担的认知相关性。传统分数和过程分数均能预测早期tau负担。情景记忆分数是最强的相关性指标之一。在考虑脑结构测量指标后,认知分数仍然具有显著性。

相似文献

1
Identifying cognitive test scores associated with early tau burden in Alzheimer's disease.确定与阿尔茨海默病早期tau蛋白负荷相关的认知测试分数。
Alzheimers Dement (Amst). 2025 Jan 14;17(1):e70052. doi: 10.1002/dad2.70052. eCollection 2025 Jan-Mar.
2
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.皮质 Tau 正电子发射断层扫描模式在临床前阿尔茨海默病患者中的差异。
JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676.
3
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
4
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
5
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum.血浆磷酸化tau217与阿尔茨海默病谱系中的记忆缺陷密切相关。
Brain. 2025 Jan 29. doi: 10.1093/brain/awaf033.
6
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.利用血浆生物标志物预测唐氏综合征患者的淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究。
Lancet Neurol. 2025 Jul;24(7):591-600. doi: 10.1016/S1474-4422(25)00158-9.
7
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
8
Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.客观记忆障碍分期与淀粉样 PET 和结构 MRI 的相关性:A4 研究。
Neurology. 2022 Mar 29;98(13):e1327-e1336. doi: 10.1212/WNL.0000000000200046. Epub 2022 Feb 23.
9
Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.认知正常或轻度认知障碍老年人的财务能力和大脑 Tau 与淀粉样蛋白负担的纵向演变。
J Prev Alzheimers Dis. 2024;11(4):966-974. doi: 10.14283/jpad.2023.121.
10
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.

引用本文的文献

1
Disease stage-specific atrophy markers in Alzheimer's disease.阿尔茨海默病中疾病阶段特异性萎缩标志物。
Alzheimers Dement. 2025 Jul;21(7):e70482. doi: 10.1002/alz.70482.
2
Disease stage-specific atrophy markers in Alzheimer's disease.阿尔茨海默病中疾病阶段特异性萎缩标志物
medRxiv. 2025 Mar 14:2025.03.13.25323904. doi: 10.1101/2025.03.13.25323904.

本文引用的文献

1
Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study.在 A4 研究中,针对种族/民族、性别和 Aβ状态组,调查临床前阿尔茨海默病认知综合指数和认知功能指数的因子结构。
J Prev Alzheimers Dis. 2024;11(1):48-55. doi: 10.14283/jpad.2023.98.
2
Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.加速阿尔茨海默病治疗药物研发:临床试验的过去与未来。
Cell. 2023 Oct 26;186(22):4757-4772. doi: 10.1016/j.cell.2023.09.023. Epub 2023 Oct 16.
3
Trial of Solanezumab in Preclinical Alzheimer's Disease.在临床前阿尔茨海默病中进行的 Solanezumab 试验。
N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.
4
Regional cerebral tau predicts decline in everyday functioning across the Alzheimer's disease spectrum.区域性大脑 tau 可预测阿尔茨海默病谱中日常功能的下降。
Alzheimers Res Ther. 2023 Jul 5;15(1):120. doi: 10.1186/s13195-023-01267-w.
5
Detection and treatment of Alzheimer's disease in its preclinical stage.阿尔茨海默病的临床前期检测与治疗。
Nat Aging. 2023 May;3(5):520-531. doi: 10.1038/s43587-023-00410-4. Epub 2023 May 18.
6
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.淀粉样蛋白和 tau 正电子发射断层扫描(PET)阳性、认知正常的个体未来认知能力下降的风险较高。
Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.
7
Impact of spill-in counts from off-target regions on [F]Flortaucipir PET quantification.脱靶区溢出计数对[F]Flortaucipir PET 定量的影响。
Neuroimage. 2022 Oct 1;259:119396. doi: 10.1016/j.neuroimage.2022.119396. Epub 2022 Jun 24.
8
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.皮质 Tau 正电子发射断层扫描模式在临床前阿尔茨海默病患者中的差异。
JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676.
9
Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.认知功能正常的老年人主观认知下降与阿尔茨海默病病理的脑脊液生物标志物的关联:CABLE 研究。
J Alzheimers Dis. 2022;85(3):1143-1151. doi: 10.3233/JAD-215178.
10
Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials.认知能力下降作为早期预防试验中向痴呆进展的结果和标志物。
Alzheimers Dement. 2022 Apr;18(4):676-687. doi: 10.1002/alz.12431. Epub 2021 Sep 5.